These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34155909)

  • 21. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-scale discriminative regions analysis in FDG-PET imaging for early diagnosis of Alzheimer's disease.
    Zhang J; He X; Qing L; Xu Y; Liu Y; Chen H
    J Neural Eng; 2022 Aug; 19(4):. PubMed ID: 35882218
    [No Abstract]   [Full Text] [Related]  

  • 23. Validation of a New Imaging Technique Using the Glucose Metabolism to Amyloid Deposition Ratio in the Diagnosis of Alzheimer's Disease.
    Takahashi R; Ishii K; Yokoyama K; For The Alzheimer S Disease Neuroimaging Initiative EY
    Curr Alzheimer Res; 2017; 14(2):161-168. PubMed ID: 27334941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empirical derivation of the reference region for computing diagnostic sensitive ¹⁸fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample.
    Rasmussen JM; Lakatos A; van Erp TG; Kruggel F; Keator DB; Fallon JT; Macciardi F; Potkin SG;
    Biochim Biophys Acta; 2012 Mar; 1822(3):457-66. PubMed ID: 21958592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies.
    Ishii K; Sasaki H; Kono AK; Miyamoto N; Fukuda T; Mori E
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):959-63. PubMed ID: 15800784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.
    Dukart J; Mueller K; Horstmann A; Vogt B; Frisch S; Barthel H; Becker G; Möller HE; Villringer A; Sabri O; Schroeter ML
    Neuroimage; 2010 Jan; 49(2):1490-5. PubMed ID: 19770055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging.
    Lee DH; Lee P; Seo SW; Roh JH; Oh M; Oh JS; Oh SJ; Kim JS; Jeong Y
    Neuroimage; 2019 Feb; 186():690-702. PubMed ID: 30503934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease.
    Luo F; Rustay NR; Ebert U; Hradil VP; Cole TB; Llano DA; Mudd SR; Zhang Y; Fox GB; Day M
    Neurobiol Aging; 2012 May; 33(5):933-44. PubMed ID: 20961663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders.
    Raji CA; Torosyan N; Silverman DHS
    J Alzheimers Dis; 2020; 77(3):935-947. PubMed ID: 32804147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.
    Yun HJ; Kwak K; Lee JM;
    PLoS One; 2015; 10(6):e0129250. PubMed ID: 26061669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a deep learning network for Alzheimer's disease classification with evaluation of imaging modality and longitudinal data.
    Deatsch A; Perovnik M; Namías M; Trošt M; Jeraj R
    Phys Med Biol; 2022 Sep; 67(19):. PubMed ID: 36055243
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer's disease.
    Carneiro CG; Faria DP; Coutinho AM; Ono CR; Duran FLS; da Costa NA; Garcez AT; da Silveira PS; Forlenza OV; Brucki SMD; Nitrini R; Busatto G; Buchpiguel CA
    Braz J Psychiatry; 2022 Aug; 44(5):495-506. PubMed ID: 36420910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
    Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
    Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
    Klupp E; Förster S; Grimmer T; Tahmasian M; Yakushev I; Sorg C; Yousefi BH; Drzezga A
    Brain Connect; 2014 Jun; 4(5):371-83. PubMed ID: 24870443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET/MRI in Alzheimer's disease.
    Yan S; Zheng C; Cui B; Qi Z; Zhao Z; An Y; Qiao L; Han Y; Zhou Y; Lu J
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2440-2452. PubMed ID: 32157432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crossed Cerebellar Diaschisis in Alzheimer's Disease.
    Reesink FE; García DV; Sánchez-Catasús CA; Peretti DE; Willemsen AT; Boellaard R; Meles SK; Huitema RB; de Jong BM; Dierckx RA; De Deyn PP
    Curr Alzheimer Res; 2018; 15(13):1267-1275. PubMed ID: 30210001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer's disease.
    Huang SY; Hsu JL; Lin KJ; Liu HL; Wey SP; Hsiao IT;
    Sci Rep; 2018 Sep; 8(1):13807. PubMed ID: 30218083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Wabik A; Trypka E; Bladowska J; Statkiewicz M; Sąsiadek M; Zimny A
    J Transl Med; 2022 Jun; 20(1):259. PubMed ID: 35672750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tracer-specific reference tissues selection improves detection of
    Li Y; Ng YL; Paranjpe MD; Ge Q; Gu F; Li P; Yan S; Lu J; Wang X; Zhou Y;
    Hum Brain Mapp; 2022 May; 43(7):2121-2133. PubMed ID: 35165964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.